US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 7.795
  • -0.105-1.33%
Trading Apr 28 15:41 ET
1.16BMarket Cap-7.22P/E (TTM)

Adaptive Biotechnologies Key Stats

Adaptive Biotechnologies Q1 2025 Estimates Date

Currency:USDMay 1, 2025

Estimate YoY
Revenue
42.13M
+0.60%
EPS
-0.30
+9.94%
Strong Buy

Apr 28, 2025

Adaptive Biotechnologies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 47.299M--
May 1, 20252025/Q1-- / 42.125M--
Feb 11, 20252024/Q447.459M / 46.049M--
Nov 7, 20242024/Q346.435M / 40.229M--
Aug 1, 20242024/Q243.190M / 39.388M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 47.299M--
May 1, 20252025/Q1-- / 42.125M--
Feb 11, 20252024/Q447.459M / 46.049M--
Nov 7, 20242024/Q346.435M / 40.229M--
Aug 1, 20242024/Q243.190M / 39.388M--

Unlock Free Earnings Estimates

Adaptive Biotechnologies Earnings Reports

Read more

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More